Safety Monitoring of a New Pentavalent Vaccine in the Expanded Programme on Immunisation in Ghana

  title={Safety Monitoring of a New Pentavalent Vaccine in the Expanded Programme on Immunisation in Ghana},
  author={A. N. Dodoo and L. Renner and A. C. Grootheest and J. Labadie and K. Antwi-Agyei and Selasie Hayibor and Johannes Addison and Victoria Pappoe and A. Appiah-Danquah},
  journal={Drug Safety},
  • A. N. Dodoo, L. Renner, +6 authors A. Appiah-Danquah
  • Published 2007
  • Medicine
  • Drug Safety
  • AbstractBackground and objective: Safety monitoring of vaccines used in expanded programmes on immunisation is important in all countries, including those with limited resources. As the rates of target diseases decrease, parents become less accepting of even minor common adverse events. Identification, detection, prevention and appropriate communication of adverse events following immunisation (AEFI) are therefore essential to preserve the integrity of immunisation programmes and protect public… CONTINUE READING
    20 Citations
    Study on the effectiveness and impact of pentavalent vaccination program in India and other south Asian countries
    • 6
    Pharmacovigilance of malaria intermittent preventive treatment in infants coupled with routine immunizations in 6 African countries.
    • 7
    • Highly Influenced
    • PDF
    Comparison of adverse events following pentavalent and diphtheria‐tetanus‐pertussis vaccines among Nigerian children
    • 1
    • Highly Influenced


    Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.
    • J. Arístegui, V. Usonis, +4 authors H. Bock
    • Medicine
    • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
    • 2003
    • 54
    A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America.
    • 30
    • PDF
    Vaccine Safety Controversies and the Future of Vaccination Programs
    • 74
    Developing a national system for dealing with adverse events following immunization.
    • 32
    • PDF